Anbalcabtagene Autoleucel in Relapsed/Refractory CNS Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Primary CNS Lymphoma (PCNSL) · Diffuse Large B Cell Lymphoma (DLBCL)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Asan Medical Center, Seoul, South Korea
Contact: Study coordinator (Hyungwoo Cho, Ph.D) · hwcho268@gmail.com · 82-2-30103205

Study leads

Hyungwoo Cho, Ph.D
Principal Investigator
Asan Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Tampa, United States

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

B-Cell Non-Hodgkin's Lymphoma (NHL) · Lymphoma, Non-Hodgkins · Lymphomas Non-Hodgkin's B-Cell

Abroad (travel likely)RecruitingPHASE1, PHASE2

Sacramento, United States · Dallas, United States

Pembrolizumab + Chemotherapy in Newly Diagnosed PCNSL

Lymphoma · Primary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE1

Boston, United States · Boston, United States

Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma

CNS Lymphoma · Primary Central Nervous System Lymphoma · Secondary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

San Francisco, United States